Symptomatic Valvular and Subvalvular Stenosis: A Case Report.

Aortic stenosis is a common valvular disease that is expected to become more prevalent with the aging population. It is often undiagnosed in socioeconomically deprived groups. Diagnosis relies on echocardiography, and additional imaging techniques such as cardiac computed tomography (CCT) and cardiovascular magnetic resonance (CMR) are increasingly used. Surgical aortic valve replacement is the standard treatment, except for high-risk cases where TAVR is recommended. Subvalvular aortic stenosis (SAS) is the second most common cause of left ventricular outflow tract obstruction. This case report highlights a 72-year-old Hispanic lady with both valvular and subvalvular aortic stenosis, emphasizing the need for specialized care and surgical intervention. Early identification, accurate assessment, and appropriate intervention are crucial for improving outcomes in aortic stenosis and subvalvular stenosis cases.

Unforeseen Complications of Pembrolizumab in Breast Reconstruction Post-Mastectomy.

A 53-year-old post-menopausal Indian female presented with invasive ductal carcinoma, treated with neoadjuvant chemotherapy and pembrolizumab due to a PD-L1 combined positive score of 5. Following a right mastectomy and axillary dissection, she received a breast expander and AlloDerm™ graft. After resuming pembrolizumab and paclitaxel postoperatively, she developed severe breast redness and high-grade fever, necessitating expander removal due to suspected pembrolizumab-induced complications. This case underscores the unique and severe adverse effects of pembrolizumab on breast reconstruction, highlighting the need for careful monitoring and management in patients undergoing similar treatments. LEARNING POINTS: Among patients with early triple-negative breast cancer, the combination of pembrolizumab with neoadjuvant chemotherapy enhances outcomes compared to chemotherapy alone.Early recognition is essential for managing pembrolizumab-induced complications, as demonstrated by the need for expander removal and debridement in this case.The unique adverse effects observed in this case underscore the importance of tailoring cancer treatment plans to individual patients, taking into account the potential risks associated with immunotherapy in the context of reconstructive surgery.